কানাডা - ইংরেজি - Health Canada

bristol-myers squibb canada - captopril - tablet - 50mg - captopril 50mg - angiotensin-converting enzyme inhibitors

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

avera mckennan hospital - captopril (unii: 9g64rsx1xd) (captopril - unii:9g64rsx1xd) - captopril 12.5 mg

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

cardinal health - captopril (unii: 9g64rsx1xd) (captopril - unii:9g64rsx1xd) - captopril 12.5 mg

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

golden state medical supply, inc. - captopril (unii: 9g64rsx1xd) (captopril - unii:9g64rsx1xd) - captopril 12.5 mg

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

redpharm drug inc. - captopril (unii: 9g64rsx1xd) (captopril - unii:9g64rsx1xd) - captopril tablets are indicated for the treatment of hypertension. in using captopril, consideration should be given to the risk of neutropenia/agranulocytosis (see warnings ). captopril may be used as initial therapy for patients with normal renal function, in whom the risk is relatively low. in patients with impaired renal function, particularly those with collagen vascular disease, captopril should be reserved for hypertensives who have either developed unacceptable side effects on other drugs, or have failed to respond satisfactorily to drug combinations. captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive. captopril tablets are indicated in the treatment of congestive heart failure usually in combination with diuretics and digitalis. the beneficial effect of captopril in heart failure does not require the presence of digitalis, however, most control

মাল্টা - ইংরেজি - Malta Medicines Authority

adelco-chromatourgia anthinon e. colocotronis bros s.a. 37 pireos str, 183 46, moschato, athens, greece - captopril - tablet - captopril 50 mg - agents acting on the renin-angiotensin system

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - captopril, quantity: 50 mg - tablet, uncoated - excipient ingredients: lactose; microcrystalline cellulose; maize starch; palmitic acid; colloidal anhydrous silica; purified talc - hypertension: captopril (captopril) is indicated for the treatment of hypertension. in using captopril, consideration should be given to the risk of neutropenia/agranulocytosis (see warnings). captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive. myocardial infarction: captopril (captopril) is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. the efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond three days post-infarction. heart failure: captopril (captopril) is indicated for the treatment of heart failure. in symptomatic patients it is recommended that captopril be administered together with a diuretic. diabetic nephrophathy: captopril (captopril) is indicated for the treatment of diabetic nephropathy in patients with type i insulin-dependent diabetes mellitus.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - captopril, quantity: 50 mg - tablet, uncoated - excipient ingredients: lactose; microcrystalline cellulose; maize starch; palmitic acid; colloidal anhydrous silica; purified talc - hypertension: captopril (captopril) is indicated for the treatment of hypertension. in using captopril, consideration should be given to the risk of neutropenia/agranulocytosis (see warnings). captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive. myocardial infarction: captopril (captopril) is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction, manifested as an ejection fraction less than or equal to 40%, and to reduce the incidence of overt heart failure and subsequent hospitalisations for congestive heart failure in these patients. the efficacy data for the use of captopril following myocardial infarction are strongest for initiation of therapy beyond three days post-infarction. heart failure: captopril (captopril) is indicated for the treatment of heart failure. in symptomatic patients it is recommended that captopril be administered together with a diuretic. diabetic nephrophathy: captopril (captopril) is indicated for the treatment of diabetic nephropathy in patients with type i insulin-dependent diabetes mellitus.

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - captopril - oral capsule - 50mg

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - captopril - oral tablet - 50mg